Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Washington DC, DC NAICS: 325412
U.S. Department of Labor's OFLC discloses 18 Labor Condition Application filings naming Vanda Pharmaceuticals Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 30 H-1B petitions naming Vanda Pharmaceuticals Inc. through FY2024, and approved nearly every one of them: 100% approved (30 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Vanda Pharmaceuticals Inc. is listed in 18 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $128,778. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Washington DC, DC.
Vanda Pharmaceuticals Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
18 12320th of 122824 higher than 110,504 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $80,000–$230,000 .
DOL LCA release change
On 18 LCAs with comparable offered vs prevailing wages, Vanda Pharmaceuticals Inc. averages about 19% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (50% of LCA filings).
Only 18 LCAs on file for Vanda Pharmaceuticals Inc., and 88.9% land in DISTRICT OF COLUMBIA, DC. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$128,778
Above portal avg
Total Workers
18
Small worker count
Compensation range for H-1B positions at Vanda Pharmaceuticals Inc.
Wage vs. DOL Minimum
+19%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Qualified (Level II)
50% of LCA filings
Full-Time Positions
100%
Primary Worksite County
DISTRICT OF COLUMBIA, DC
88.9% of LCA filings
Most frequently listed job titles at Vanda Pharmaceuticals Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Clinical Data Manager | 3 | $88,333 |
| Sr. Statistical Analyst | 2 | $115,000 |
| Sr. Software Engineer | 2 | $170,000 |
| Sr. Scientist, Formulations Development | 2 | $125,500 |
| Bioinformatics Scientist | 2 | $142,500 |
| Statistical Analyst | 1 | $105,000 |
| Senior Scientist, Analytical Chemistry | 1 | $125,000 |
| Senior CMC Regulatory Scientist | 1 | $138,000 |
| Manager, Statistical Programming | 1 | $130,000 |
| Manager, QA/CMC Regulatory | 1 | $119,000 |
| Director Biostatistics | 1 | $230,000 |
| Data Engineer | 1 | $100,000 |
Cross-state DOL neighbors for Vanda Pharmaceuticals Inc. - LCA filing-count and offered-wage axes, outside DC.
Nearest cross-state employer filers by LCA filing count (18 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($128,778 here).
Vanda Pharmaceuticals Inc. is listed in 18 DOL Labor Condition Application filings covering 18 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Vanda Pharmaceuticals Inc. ranks #11818 by total LCA filing count (18 filings). 110,504 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Vanda Pharmaceuticals Inc. has a 100% DOL certification rate, with 18 out of 18 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Vanda Pharmaceuticals Inc.'s LCAs is $128,778. Listed wages range from $80,000 to $230,000 and are not verified actual compensation.
The top job titles in Vanda Pharmaceuticals Inc.'s LCA filing records include Clinical Data Manager, Sr. Statistical Analyst, Sr. Software Engineer. The most common listed title is Clinical Data Manager with 3 LCA filings at an average listed offered wage of $88,333. This does not establish actual job openings, hiring, or approved petitions.
Vanda Pharmaceuticals Inc. is headquartered in Washington DC, DC.
No, Vanda Pharmaceuticals Inc. is not classified as H-1B dependent.
Vanda Pharmaceuticals Inc. is listed in 5 LCA filings in FY2023 and 1 in FY2026. The average listed offered wage increased from $121,800 to $230,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Vanda Pharmaceuticals Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Vanda Pharmaceuticals Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Vanda Pharmaceuticals Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 18 LCAs (Δ 0 heavier vs Vanda Pharmaceuticals Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
DC pole at 497 LCAs stamps MID-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Vanda Pharmaceuticals Inc.'s MICRO-BOOK.
Open the DC state board after the ABS peers. Vanda Pharmaceuticals Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Vanda Pharmaceuticals Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Vanda Pharmaceuticals Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.